KEY HIGHLIGHTS:-

The Reserve Bank of Indian (RBI) on Friday decided to keep the benchmark repo rate unchanged at 4 per cent, already at the lowest since 2000, and reverse repo rate at 3.35 per cent. RBI said it would reverse the 100-basis-point cash reserve ratio in two tranches back to 4% by May 22, 2021.RBI announced the direct participation of Retail investors to invest in G-sec while earlier it was done through banks. Real GDP Growth is projected at 10.5% in 2021-2022 and CPI inflation is projected at 5.2% for Q4FY21 , 5.2- 5% in the H1FY22 and at 4.3% in the Q3FY22. Gross market borrowing of Centre is estimated at Rs 12 lakh crore.

The Yield on a 10-year benchmark federal paper, 05.77 GS 2030 edged up by 5 basis points to 6.14% compared to 6.09% in the previous trading session. The Total trading volume on the central banks gilts trading platform stood at Rs 14695 crore.

Globally, US real gross domestic product increased by 4% (Q-o-Q) in the 4th quarter, according to the advance estimate released by the Bureau of Economic Analysis.

Trade AnyTime Any Where With Elite Empower Mobile App

Elite-Empower-App-Promotional-Banner-img1

FII/FPI IN DEBT MARKET

DATE PURCHASES SALES NET(cr)
Week ended 5th Feb 1174.71 775.23 399.48
Week ended 29th Jan 654.51 423.18 231.33

 

fill flip debt in market elite

GLOBAL INDICES

INDEX     As on

     5th feb

As on

29th Jan

%Chg.
S&P BSE SENSEX 50731.693 46,285.77 9.61%
NIFTY 50 14924.25 13,634.60 9.46%
NASDAQ 13856.3 13,070.70 6.01%
FTSE 100 6489.33 6,407.46 1.28%

 

POLICY RATES

INSTRUMENT Rate
Policy Repo Rate 4.00%
Reverse Repo Rate 3.35%
MSFR 4.25%
Bank Rate 4.25%
CRR 3.00%
SLR 18.00%
GDP -7.5%

 

EXCHANGE RATES

Rate               As on

  5th Feb

As on

29th Jan

%Chg.
USD/INR 73.08 73.16 -0.11%
EUR/INR 87.58 88.78 -1.35%
GBP/INR 99.95 100.19 -0.24%
JPY/INR 69.25 69.86 -0.87%

 

USD INR market

MACRO DATA

PARTICULARS CURRENT PREVIOUS
Foreign Exchange Reserves (5th/Feb. 2021) $590.19B $585.33B
WPI Inflation YoY (Dec) 1.22% 1.55%
Inflation Rate YoY (Dec) 4.59% 6.93%

 

DOMESTIC INDICATORS

INSTRUMENT As on

5th Feb

As on

29th Jan

10 yr bond yield 6.07% 5.95%
3yr bond yield 4.97% 4.71%
1yr bond yield 4.06% 3.90%
US 10 yr benchmark yield 1.17% 1.07%

 

COMMODITY

INSTRUMENTS As on

5th Feb

As on

29th Jan

%Chg.
CRUDE OIL 56.85 52.2 8.91%
GOLD($) 1,815.10 1,850.30 -1.90%
SILVER($) 27.019 26.914 0.39%

(Source:Bloomberg,RBI,Investing,BusinessStandard,CapitalNews)

Market view

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors

Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their

investment decision and must exercise their own judgment before making any investment decision.

 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors

Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their

investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Advisors

Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Israil Khan, Elite Wealth Advisors Limited, suhail@elitewealth.in

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their

securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this

report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Advisors Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that

the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the

report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment

thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Advisors Limited covered companies by visiting https://www.elitewealth.in, or emailing

research@elitestock.com with your request. Elite Wealth Advisors Limited may screen companies based on Strategy, Technical, and Quantitative Research.

For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure

documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available

to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Advisors Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of

coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Advisors Limited. Analyst as officer or director: Elite Wealth

Advisors Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company

in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. RavinderParkash Seth is the Managing Director of Elite Wealth Advisors Ltd (EWAL, henceforth), having its registered office at Casa Picasso, Golf Course

Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and

Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWAL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research

report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWAL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWAL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of

the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWAL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public

appearance;

  1. Compensation

(a) EWAL Advisory or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWAL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWAL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company

in the past twelve months;

(d) EWAL Advisory or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage

services from the subject company in the past twelve months;

(e) EWAL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research

report.

3 In respect of Public Appearances

(a) EWAL Advisory or its associates have not received any compensation from the subject company in the past twelve months;

(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided

by EWAL Advisory

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of

clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or

brokerage services transactions of the subject company.

(4) EWAL Advisory or its proprietor has never served as an officer, director or employee of the subject company;

(5) EWAL Advisory has never been engaged in market making activity for the subject company;

(6) EWAL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.